Technology

Pfizer-Allergan Deal Scrapped Due to New US Tax Inversion Rules

With the issuance of the new tax inversion laws on Monday, Obama became the victor since Pfizer scrapped its $160-billion deal with Allergan Plc. If that deal had materialized, it could have enabled the U.S. drug maker to keep a large chunk of its profits out of reach of the country’s tax collectors.